Dr Sabine Renker, Head of AT R&D
Oct 02, 2012.
If you already have access, please [Login]
Access can be purchased via IDTechEx Credits
Speaker Biography (Sabine Renker)
Dr. Renker started her career in 2005 with Merck KGaA in Darmstadt where she worked in the field of nano-particle development for UV-protection for coatings.
Following this she managed from 2008-2010 the joined R&D lab of Merck and TU Darmstadt (MerckLab), focusing on the development of printed inorganic electronics. Since 2011 she is Head of Advanced Technologies R&D Japan (Concept Lab Japan), with the strategic focus on optoelectronics and energy. It is tasked with supporting existing businesses, developing new products for markets with mid and long-term growth potential, and scouting the Japanese scientific landscape to identify new potential collaboration partners for Merck.
Company Profile (Merck KGaA)
View Merck KGaA Timeline
Merck KGaA of Darmstadt, Germany, is a leading company for innovative and top-quality high-tech products in the pharmaceutical and chemical sectors. Its subsidiaries in Canada and the United States operate under the umbrella brand EMD. Around 39,000 employees work in 66 countries to improve the quality of life for patients, to further the success of customers and to help meet global challenges. The company generated total revenues of € 11.1 billion in 2013 with its four divisions: Biopharmaceuticals, Consumer Health, Performance Materials and Life Science Tools. Merck KGaA of Darmstadt, Germany is the world's oldest pharmaceutical and chemical company - since 1668, the name has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent interest, the founding family remains the majority owner of the company to this day.